News & Events
< Back to News Overview
Leading Australian Heart Surgeon Joins Sunshine Heart Inc Medical Advisory Board
08 / 06 / 2005
Sunshine Heart, Inc., (ASX: SHC) today announced that Professor Don Esmore has accepted its invitation to join the Company's medical advisory board.
Donald Rohrbaugh, CEO of Sunshine Heart, Inc., commented "We are delighted that Don Esmore has agreed to join our medical advisory board. Don has many years of experience in heart transplantation and in the use of innovative devices for the treatment of heart failure. I had the pleasure of working with Don when he did the first placement of the Novacor heart assist device in Australia in the early 80s. Since then Don has been involved in a number of other world leading procedures and devices to treat heart failure."
"I am pleased to accept this invitation to join the medical advisory board of Sunshine Heart Inc." said Professor Esmore. "The C-Pulse device developed by Sunshine Heart works on quite a different principle to that used in more conventional heart assist devices. This may prove to make the device suitable for less sick patients. If this is the case it will offer the medical community a device useful in patients who are already on maximal drug therapy and for whom there is no alternative treatment."
Professor Don Esmore is a Clinical Associate Professor, and Head of Cardiac Transplantation, at the Alfred Hospital in Melbourne. He has published extensively on heart transplantation and the use of devices for the treatment of heart failure. Professor Esmore joins a distinguished medical advisory board providing advice to Sunshine Heart Inc. This board includes Professor Michael Acker MD, Pennsylvania State University, Professor Robert C. Robbins MD, Stanford University Medical Centre and Professor James Young MD, Chairman of Medicine, Cleveland Clinic.
More information about the C-Pulse heart assist device may be obtained at www.sunshineheart.com.
Donald Rohrbaugh, CEO of Sunshine Heart, Inc., commented "We are delighted that Don Esmore has agreed to join our medical advisory board. Don has many years of experience in heart transplantation and in the use of innovative devices for the treatment of heart failure. I had the pleasure of working with Don when he did the first placement of the Novacor heart assist device in Australia in the early 80s. Since then Don has been involved in a number of other world leading procedures and devices to treat heart failure."
"I am pleased to accept this invitation to join the medical advisory board of Sunshine Heart Inc." said Professor Esmore. "The C-Pulse device developed by Sunshine Heart works on quite a different principle to that used in more conventional heart assist devices. This may prove to make the device suitable for less sick patients. If this is the case it will offer the medical community a device useful in patients who are already on maximal drug therapy and for whom there is no alternative treatment."
Professor Don Esmore is a Clinical Associate Professor, and Head of Cardiac Transplantation, at the Alfred Hospital in Melbourne. He has published extensively on heart transplantation and the use of devices for the treatment of heart failure. Professor Esmore joins a distinguished medical advisory board providing advice to Sunshine Heart Inc. This board includes Professor Michael Acker MD, Pennsylvania State University, Professor Robert C. Robbins MD, Stanford University Medical Centre and Professor James Young MD, Chairman of Medicine, Cleveland Clinic.
More information about the C-Pulse heart assist device may be obtained at www.sunshineheart.com.